Manier, S., Ocio, E. M., Martínez-Chamorro, C., Delimpasi, S., Oriol, A., Dimopoulos, M. A., Leleu, X. P., Rubinstein, S., Joseph, N. S., Mesa, M. G., Chakraborty, R., Larrea, C. F. D., Breazna, A., Drew, J., Boyapati, A., Hazra, A., Kroog, G. S., Sarkaria, S. M., Rodriguez-Otero, P. (2025). Linvoseltamab (LINVO) + carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial results from the LINKER-MM2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7513